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Gap junctions are intercellular channels that are formed by the protein family of connexins (Cxs). In mammary tissue, Cx26 and Cx32 are
present in the secretory epithelium and Cx43 is localized in the myoepithelium. The expression of Cx26 and Cx32 is induced during
pregnancy and lactation, respectively, thus suggesting unique roles for them in the functional development of the gland. The requirement for
these connexins was explored using several strains of genetically altered mice: mice with an inactivated Cx32 gene, mice in which the Cx43
gene had been replaced with the Cx32 gene (Cx43KI32 mice) and mice in which the Cx26 gene was specifically ablated in mammary
epithelium at different stages of development using Cre-loxP-based recombination. Normal mammary development was obtained in Cx32-
null mice and in Cx43KI32 mammary tissue. In contrast, loss of Cx26 in mammary epithelium before puberty resulted in abrogated lobulo-
alveolar development and increased cell death during pregnancy, which was accompanied by impaired lactation. Loss of Cx26 in mammary
epithelium during the later part of pregnancy did not adversely interfere with functional mammary development. These results demonstrate
that the presence of Cx26 is critical during early stages but not during the end of pregnancy when the tissue has completed functional
differentiation. Cx26 is considered a tumor suppressor gene and Cx26-null mammary tissue was evaluated after five pregnancies. No
hyperproliferation or hyperplasia was observed, suggesting that Cx26 does not function as a tumor suppressor.
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Introduction cells. Nineteen genes encoding connexins have been iden-Cells within the context of an organ communicate
directly with each other and thereby coordinate their
activities. Such communication is facilitated by gap junc-
tions, which are unique membrane structures composed of
clusters of channels connecting neighboring cells. The
channels are built by hexamers of connexins (Cxs), which
are integral membrane proteins. Molecules smaller than 1
kDa, such as calcium and cyclic AMP, can travel through
these channels and convey rapid communications between0012-1606/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.ydbio.2003.11.022
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expressed in a rather cell-restricted pattern (Willecke et
al., 2002). Connexins 26, 32 and 43 are highly expressed
in mammary tissue and several lines of investigation
suggest that they might be important for its development
during pregnancy and function during lactation (Pozzi et
al., 1995). Most notably, connexins 26 and 32 have been
co-localized in gap junctions of mouse mammary epithe-
lium during lactation and both homomeric and heteromeric
connexins have been identified (Locke et al., 2000). The
unique expression patterns of connexins 26 and 32 suggest
distinct and overlapping roles in mammary development
and function. Cx26 mRNA and protein have been detected
in mouse mammary tissue as early as day 4 of pregnancy,
which is followed by a steady increase and maximal
expression during lactation (Locke et al., 2000; Monaghan
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expression occurs only within a few hours after parturition
(Locke et al., 2000). A similar expression profile has been
established in the rat (Yamanaka et al., 2001). In contrast
to Cx26 and Cx32, Cx43 is not detected in the secretory
epithelium but rather the myoepithelium, and its expression
increases sharply after parturition (Monaghan et al., 1996;
Yamanaka et al., 1997). A role in the coordination of the
contraction of the myoepithelium was hypothesized.
The finding that Cx26 is the dominant gap junction
protein in acinar cells during pregnancy suggests that these
channels may be critical for normal development, such as
alveolar expansion and differentiation. Conversely, the
induction of Cx32 after parturition points to a role in
the establishment and/or maintenance of secretory func-
tions. Experimental mouse genetics provides a powerful
tool to define the function of a protein, but it has its
limitations in that the redundancy of proteins within a
family may obscure their function. For example, the loss
of Cx32 does lead to a rather restricted set of lesions (for
review, see Willecke et al., 2002) and the presence of
Cx26 is essential for placental function (Gabriel et al.,
1998). The expression pattern of Cx26 during pregnancy
(Locke et al., 2000) mimics that of some milk proteins,
including WDNM1 and h-casein (Robinson et al., 1995)
suggesting that the gene is subject to similar hormonal
control mechanism, including the Jak2/Stat5 pathway. In
support of this, a Stat5 binding site has been identified in
the promoter region of the human and mouse Cx26 gene
(Kiang et al., 1997).
To explore the unique contributions of Cx26 to alveolo-
genesis and epithelial differentiation and function, we inac-
tivated the gene specifically in mammary epithelium using
Cre-loxP-based recombination. Two specific Cre-expressing
mouse lines were used that exhibit distinct expression
patterns. WAP-Cre (WC) mice display Cre expression in
the later part of pregnancy when the alveoli have already
formed, and differentiation has been initiated (Wagner et al.,
1997, 2001). In contrast, the MMTV-Cre (MC) mice express
Cre recombinase already in mammary epithelium at the time
of birth (Wagner et al., 1997, 2001), and the Cx26 gene will
be inactivated at all stages of mammary development.
Furthermore, the role of connexin 32 was established during
the differentiation and lactation phase of mammary tissue in
Cx32-null mice. Lastly, the contribution of Cx43 was
evaluated in mice in which the Cx43 genes had been
replaced with Cx32 alleles.Materials and methods
Mice
Mice in which the Cx32 gene had been inactivated
(Nelles et al., 1996) and the Cx43 gene had been replaced
with the Cx32 gene (Plum et al., 2000) have been described.The Cx26 gene was inactivated in mammary epithelium
using MMTV-Cre and WAP-Cre transgenes (Wagner et al.,
1997, 2001) that were introduced into mice where exon 2 of
Cx26, the coding region of the gene, is flanked by loxP site
(Cohen-Salmon et al., 2002) (Fig. 4I). To distinguish
between wild-type and floxed alleles, primers were used
that flank a loxP site. Primer 1 (5V-ACA GAA ATG TGT
TGG TGA TGG-3V) is located 204 bp before exon 2 and
primer 2 (5V-CTT TCC AAT GCT GGT GGA GTG-3V) is
located 65 bp after the beginning of exon 2. A fragment of
289 bp was amplified from the wild-type allele and a 390-bp
fragment from the floxed allele. The MMTV-Cre transgene
was identified with two primers (5V-CGT TCT GAT CTG
AGC TCT GAG TG-3Vand 5V-CAT CAC TCG TTG CAT
CGA CCG G-3V) that generated a 280-bp fragment. The
WAP-Cre transgene was identified with two primers (5V-TAG
AGC TGT GCC AGC CTC TTC C-3Vand 5VCAT CAC TCG
TTG CAT CGA CCG G 3V) that generated a 240-bp PCR
fragment. Mice carrying two floxed Cx26 alleles and the
WAP-Cre or MMTV-Cre transgene are referred to through-
out the text as Cx26 fl/fl; WC and Cx26 fl/fl; MC mice,
respectively.
Mammary epithelial transplantation
The technique has been described elsewhere (Robinson
and Hennighausen, 1997). Mammary tissue from virgin
Cx43KI32 mice was transplanted into cleared fat pads of
3-week-old female athymic nude mice (nu/nu). A total of 17
transplanted mice was used for this analysis. Eight weeks
after transplantation, 8 transplanted mice were mated. Trans-
planted mammary tissue was harvested from virgin mice 11
weeks after transplantation and at day 1 of lactation.
Whole-mount analysis
After anesthesia with proper anesthetic, number 4
glands were harvested from all the different transgenic
mice at 6 weeks of age and at lactation day 1. Virgin
and lactating mammary tissues were fixed 4 h in Carnoy’s
fixative (6 parts 100% ethanol, 3 parts CHCl3, 1 part
glacial acetic acid), washed in ethanol 70%, dehydrated
by passing through decreasing ethanol concentration,
stained overnight in carmine alumin, rehydrated through
increasing ethanol concentrations, cleared in xylene and
mounted with Permount.
H&E analysis
For histological analyses, we harvested number 4
glands of 6-week-old virgin and lactation day 1 mice from
all the transgenic mice. Tissues were fixed in 4% parafor-
maldehyde (PFA) for 4 h at room temperature, dehydrated
and embedded in paraffin. Tissue blocks were sectioned at
5 Am and stained with hematoxylin and eosin by standard
methods.
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Number 4 glands of Cx26 fl/fl; WC and Cx26 fl/fl;
MC mice were harvested at day 1 of lactation and
genomic DNA was isolated by digesting the tissue in a
solution consisting of proteinase K (20 ng/ml) in 1%
SDS, 50 mM Tris–HCl at pH 8.0, 20 mM NaCl and 1
mM EDTA. Upon extraction with phenol–chloroform, the
DNA was precipitated in ethanol, air-dried and resus-
pended in TE. Thirty micrograms of genomic DNA was
digested O/N at 37jC with SpeI and BamHI and sepa-
rated in a 0.8% TAE gel. The DNA was subsequently
blotted onto a nylon membrane and hybridized with a
32P-labeled probe (described below) O/N at 65jC with
QuickHyb (Stratagene) and sheared salmon sperm DNA.
Membranes were washed with 2 SSC, 0.1% SDS for
20 min at 65jC and twice with 2 SSC, 0.01% SDS for
20 min at 65jC, and then exposed on autoradiography
film.
Template DNA to be used as a probe in the Southern
analysis was amplified from C57BL/6 mouse genomic
DNA using the following primers: 5V-CCAGCTCTG-
TATTTTGGGTCAGG-3Vand 5V-ACCAGTTGCTGGTC-
CAAGGAGC-3V. This probe is part of the intron upstream
of Cx26 exon 2 (Fig. 4I). The PCR product was separated in
a 1% TAE gel and purified using a gel extraction kit
(Qiagen).
Immunohistochemical analysis
Tissues specimens were harvested from 6-week-old vir-
gin and lactation day 1 mice from all genotypes described
previously. The tissues were fixed in PFA for 4 h at room
temperature and embedded in paraffin. Sections were boiled
in an antigen unmasking solution (Vector Laboratories, Inc.)
for 2 min followed by 10 min cooling down. Primary
antibodies were applied (NKCC1, 1:1000; Npt2b, 1:100;
E-cadherin, 1:100; h-catenin, 1:100; K5, 1:200; SMA,
1:1000; H-3, 1:100; Stat 5a, 1:100; Stat 3, 1:100; Cx26,
1:100) and the sections were incubated for 1 h at 37jC or O/
N at 4jC for Stat 5, Stat 3 and Cx26 antibodies. Subse-
quently, sections were incubated with fluorescent-conjugat-
ed secondary antibodies (Molecular Probes, Inc.) for 1 h at
room temperature in the dark. Mounting medium (Vecta-
shield, Vector Laboratories, Inc.) was applied, and the
sections were analyzed under a Zeiss Axioskop (Carl Zeiss,
Inc.) equipped with filters for fluorescein isothiocyanate
(FITC), tetramethyl rhodamine isothiocyanate (TRITC) and
FITC:TRITC and DAPI.
TUNEL assay
The TUNEL assay was performed according to the
manufacturer’s protocol (Apoptag kit, Intergen) on samples
from Cx26 fl/f; MC and wild-type control mice at pregnan-
cy day 19. A total of three mice of each genotype was used.
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from each sample. The number of apoptotic cells is
expressed as a percentage of the total number of DAPI-
stained cells.
Cell proliferation
To mimic the pregnancy and thus study the proliferation
function of the glands, 8-week-old virgin mice (wild type
and Cx26 fl/fl; MC) were treated during 48 h with 1 Ag h-
estradiol and 1 mg progesterone in 100 Al sesame oil via in-
terscapular subcutaneous injection (one injection each 24 h).
Number 4 glands were harvested and fixed in 4% PFA
during 4 h at room temperature. Immunostaining was
performed as described above using anti-phosphorylated
Histone-3 (H-3) antibodies. This antibody is specific for
mitotic cells. Six glands per genotype were used for each
experiment. Cells from five fields at 40 magnification
were counted from each sample. The number of H-3-
positive cells in a given field was expressed as a percentage
of the total number of DAPI-stained cells.Results
Expression of connexins in mouse mammary tissue
Although it had been shown that the genes encoding
connexins 26, 32 and 43 are expressed in mammary tissue,
their relative expression levels were not known. Unigene
clusters were established from the entire set of EST data-
bases as a means to determine the relative expression levels
of Cx26, Cx32 and Cx43. More than 300,000 EST clones
had been sequenced from a variety of mouse mammary
cDNA libraries (Dupont et al., 2002; Miyoshi et al., 2002).
Because most of these libraries were not normalized, it was
possible to directly compare the expression levels of indi-
vidual genes and estimate the relative expression in different
physiological states of the gland. While 27% of the Cx26
ESTs were derived from mammary libraries, 6% of the
Cx32 and 5% of the Cx43 EST clones were from mammary
libraries (Table 1). The Cx26 unigene cluster contained 210
EST clones, with 43 from a cDNA library prepared from
hyperplastic mammary tissue during lactation (WAP-TGFa
transgenic mice), and 3 were found in libraries prepared
from virgin (NbMMG) and lactating (NMLMG) tissues. In
contrast, 189 EST clones corresponded to Cx32 mRNA, 4 of
which came from the RIKEN lactating library and 6 from
the WAP-TGFa library. The highest expression level with
932 matches was determined for Cx43, with 46 hits in
mammary tissue. Twenty-five of these were found in the
cDNA library from transgenic mice that expressed the
SV40TAg. From the three connexins, Cx26 exhibited the
highest expression levels in developing and functional
mammary tissue, suggesting a role in the differentiation
process.
Table 1
Relative expression of Cx26, Cx32 and Cx43 as measured by their abundance in EST libraries from mammary and non-mammary origin
EST
total
EST in
mammary
libraries
EST LactL/
EST Mam L
NbMMG NMLMG Riken
lactation
Mam1 Mam2 Mam3 Mam4 Mam5 Mam6
Cx26 210 27% 83% 1 2 3 6 3 0 0 43 0
Cx32 189 6% 92% 1 1 4 0 0 0 0 6 0
Cx43 932 5% 13% 4 0 2 1 9 0 1 4 25
Column 2: Percentage of clones in mammary libraries compared to the entire set of EST clones in GenBank databases. Column 3: Percentage of EST present in
lactating mammary libraries compared to the total of ESTs expressed in mammary libraries. The following libraries of mouse mammary origin have been
searched. NbMMG, from virgin mice (39,638 clones); NMLMG, from lactating mice (422,777 clones); RIKEN, day 10 lactation (9921 clones); Mam_1,
derived from a mammary tumor dissected from a virgin mouse carrying a human TGFa transgene under control of a metallothionein promoter (Smith et al.,
1995b); Mam_2, derived from MMTV-LTR-Int3/Notch4 transgenic mouse mammary tumor (Smith et al., 1995a); Mam_3, from mice in which the BRCA1
gene had been inactivated (Xu et al., 1999); Mam_4, from mice which express the SV40Tag under control of the WAP gene promoter (Li et al., 1996); Mam_5,
from lactating mice which express TGFa under control of the WAP gene promoter (Humphreys and Hennighausen, 2000; Sandgren et al., 1995); Mam_6; from
mice which express the SV40Tag under control of the C3(1) promoter (Shibata et al., 1999). Bold, lactating mammary library.
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alveologenesis
To explore whether functional development of mammary
epithelium during puberty and pregnancy was uniquely
dependent on specific connexins, mice were analyzed in
which the genes encoding the individual connexins had
been inactivated. Three types of mice were used: mice that
carried an inactive Cx32 gene (Cx32-null), mice in which
the Cx43 gene had been replaced with the Cx32 gene
(Cx43KI32) and mice in which the Cx26 gene was inacti-
vated specifically in mammary epithelium. Development of
mammary tissue was evaluated during puberty (Fig. 1). The
mammary anlage is established during the fetal stage but
ductal and alveolar development is confined to puberty and
pregnancy, respectively. The elongation and branching of
mammary ducts occurs during puberty and is activated by
ovarian steroid hormones (Figs. 1A–D). Puberty-mediated
ductal elongation and branching was normal in Cx32-null
and Cx43KI32 females (Figs. 1M–T). To inactivate the
Cx26 gene specifically in mammary epithelium, two distinct
Cre transgenes were introduced into Cx26 fl/fl mice, which
resulted in the loss of the protein coding exon. While Cre
expression under control of the WAP gene promoter (WC
mice) is confined to differentiating mammary epithelium
after mid-pregnancy, Cre expression under control of the
MMTV-LTR (MC mice) occurs already in ductal epithelium
before puberty and throughout subsequent stages (Wagner et
al., 1997, 2001). Puberty-mediated ductal elongation and
branching was normal in Cx26 fl/fl; and WC Cx26 fl/fl; MC
mice (Figs. 1E–L). This demonstrates that Cx26 is not
required for the formation of ductal epithelium.
Development of mammary epithelium was further eval-
uated during pregnancy and lactation (Fig. 2). Normal
mammary epithelial cells proliferate and differentiate during
pregnancy (Figs. 2A–D), a process that is completely
dependent on a functional prolactin receptor, Jak2 and Stat5.
At the end of pregnancy, the fat pad is filled with alveolar
units that display a secretory behavior. Fat droplets and
other milk components are being secreted into the lumen ofalveoli. Cx32-null dams were able to nurture their pups and
proliferation and differentiation of mutant mammary tissue
during pregnancy was indistinguishable from that of wild-
type epithelium, as judged by histology (Figs. 2M–P). This
demonstrates that Cx32 is not required for functional
mammary development. Because Cx43KI32 mice are infer-
tile, it was necessary to transplant their mammary epitheli-
um into wild-type hosts and evaluate its development after
one pregnancy (Figs. 2Q–T). On the basis of histological
criteria, Cx43KI32 mammary epithelium had undergone
functional differentiation, lumina were filled with secretion
and displayed lipid droplets (Fig. 2T). WAP-Cre-mediated
inactivation of the Cx26 gene did not impair functional
mammary development during pregnancy and the mice
could lactate and nurse their pups. In contrast, lactation of
Cx26 fl/fl; MC mice was severely impaired. Thirteen litters
with a total of 82 pups were obtained and only 46 pups
survived to weaning age. Two dams were incapable to nurse
and their pups were dead within 24 h after parturition. While
the histological features of Cx32-null, Cx43KI32 and Cx26
fl/fl; WC mammary tissue at parturition were identical to
those observed in wild-type mice (Figs. 2A–H and M–T),
mammary tissue in Cx26 fl/fl; MC mice was severely
underdeveloped (Figs. 2I–K). Notably, there was a paucity
of alveolar epithelium ( Fig. 2K). However, some alveoli
developed during pregnancy and they displayed features of
differentiation with the secretion of lipid droplets (Fig. 2L).
The lack of sufficient mammary epithelium suggests that
Cx26 is required for the proliferation and/or survival of
epithelial cells (see below).
To further define the time window when Cx26 was
critical for alveolar development, mammary tissue from
Cx26 fl/fl; MC was analyzed at days 8.5, 9.5, 13.5, 15.5
and 19 of pregnancy. Alveolar development, as judged by
epithelial density within the fat pad, appeared to be normal
at days 8.5 and 9.5 of pregnancy (data not shown). How-
ever, a clear paucity of alveolar epithelium was observed in
Cx26 fl/fl; MC mice at day 15.5 of pregnancy (Fig. 3C).
Wild-type tissue had twice as many alveolar units as mutant
tissue (710 alveoli in panel A versus 280 alveoli in panel C).
Fig. 1. Histological analyses of mammary tissue from wild-type control and mutant virgin mice (6 weeks old). (A–D) Wild type. (E–H) Cx26 fl/fl; WC. (I–L)
Cx26 fl/fl; MC. (M–P) Cx32KO. (Q–T) Cx43KI32. (A, E, I, M, Q, B, F, J, N, R) Whole-mount analyses. (C, G, K, O, S, D, H, L, P, T) H&E analyses of
sectioned tissue. Puberty-mediated ductal elongation and branching in mutant tissues was indistinguishable from wild-type controls. Arrows, terminal end
buds; Lu, lumen; red scale bar, 1 mm; black scale bar, 100 Am; blue scale bar, 50 Am.
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entiation than mutant tissue as evidenced by its secretory
activity (Figs. 3B and 3D). No discrepancies in the differ-
entiation status were observed at parturition.
A critical aspect in using the Cre-loxP recombination
system is its overall efficiency, which depends on the Cre-
expressing mouse strain and possibly the target gene. WAP-
Cre and MMTV-Cre induced recombination and inactivation
of the Cx26 gene at day 1 of lactation was demonstrated by
Southern blot analysis (Fig. 4). Restriction of genomic DNA
from wild-type mice with BamHI and SpeI, followed by
separation in agarose gels and probing with an internalprobe, resulted in the detection of a 4-kbp fragment (Fig.
4 I). In contrast, the floxed and recombined alleles provided
6.1 and 2.1 kbp fragments, respectively. To avoid problems
with selective pressure and the potential loss of Cx26-null
cells, DNA from fl/+; MC mice was initially tested. Because
the MC transgene is active in B-cells in the spleen (Wagner et
al., 2000), this tissue was used as a positive control. The
presence of the 2.1-kbp recombined fragment demonstrated
the activity of the MC transgene (Fig. 4, IIA). Analysis of
mammary tissue from a day 15 pregnant fl/+; MC mouse
demonstrated that the floxed allele had undergone Cre-
mediated recombination (Fig. 4, IIB). Because the MC
Fig. 2. Histological analyses of mammary tissue from wild-type control and mutant lactating mice (lactation day 1). (A–D) Wild type. (E–H) Cx26 fl/fl; WC.
(I–L) Cx26 fl/fl; MC. (M–P) Cx32KO. (Q–T) Cx43KI32. (A, E, I, M, Q, B, F, J, N, R) Whole-mount analyses. (C, G, K, O, S, D, H, L, P, T) H&E analyses
of sectioned tissue. Cx26 fl/fl; MC tissue mammary was underdeveloped (I–K): we observed less alveoli (J) and the fat pad was not fully filled (K) but the
resident alveoli appeared functional as they contained lipid droplets (K and L). Open arrowheads, alveoli; solid arrowheads, lipid droplets; red scale bar, 1 mm;
black scale bar, 100 Am; blue scale bar, 50 Am.
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it is likely that the remaining signal for the 6.1-kbp floxed
allele was derived from the stromal compartment. Analysis
of mammary tissue from Cx26 fl/fl; MC and Cx26 fl/fl; WC
dam at parturition revealed that the majority of the floxed
alleles had undergone recombination (Fig. 4, IIC and IID).
To further establish the loss of Cx26 protein from
mammary epithelium an immunostaining approach was
used (Fig. 4, III). While Cx26 was observed between
adjacent epithelial cells in tissue from wild-type mice
(Fig. 4, IIIA), no Cx26 plaques were detected in the
epithelium from Cx26 fl/fl; MC mice (Fig. 4, IIIB).Analysis of epithelial cell differentiation in the absence of
Cx26, 32 and 43
To further determine the extent of differentiation of
mammary epithelium in the absence of Cx26, the tempo-
ral expression pattern of proteins that characterize either
ductal or secretory alveolar epithelium was established. In
lactating wild-type mice, h-catenin is preferentially locat-
ed in the lateral membranes of the epithelium (Fig. 5A, in
green), whereas Keratin 5 (K5) is expressed in the basally
located myoepithelial cells (Fig. 5A, in red). Smooth
muscle actin (SMA) characterizes myoepithelial cells
Fig. 3. Histological analysis of mammary tissue at pregnancy day 15.5. (A, B) H&E staining of WT gland. (C, D) H&E staining of Cx26 fl/fl; MC gland. At
early stages of pregnancy, mammary development is already severely impaired in the transgenic model. Arrow, lipid droplets. Scale bar: 50 Am.
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green) (Shillingford et al., 2002). In contrast, the Na–K–
Cl-cotransporter NKCC1 is expressed at high levels in
ductal epithelial cells of virgin mice (data not shown) and
is undetectable in secretory epithelium after parturition
(Fig. 5B) (Shillingford et al., 2002, 2003). In secretory
epithelial cells, E-cadherin is preferentially located on the
lateral membranes of the epithelium (Fig. 5C, in green),
whereas the Na–Pi cotransporter Npt2b is located on the
apical membranes and thus serves as a marker of differ-
entiation during lactation (Fig. 5C, in red) (Shillingford et
al., 2002). In secretory epithelial cells, Stat5a is found in
the nucleus (Fig. 5D, in red). As lactation was impaired in
Cx26 fl/fl; MC mice, we addressed the question if milk
ejection could be involved and then evaluated the expres-
sion of K5 and SMA. Expression of h-catenin/K5 (Figs.
5E and 5I) and SMA/NKCC1 (Figs. 5F and 5J) in both
Cx26 fl/fl; WC and Cx26 fl/fl; MC mice at parturition
was indistinguishable from control tissue. The expression
of Npt2b was normal in Cx26 fl/fl; WC (Fig. 5G) and
Cx26 fl/fl; MC (Fig. 5K) mice. Although Cx26 fl/fl; MC
mammary tissue did not expand during pregnancy, ex-
pression of Npt2b was apparent on the apical membrane
of alveolar-like structures (Fig. 5K) and Stat 5a had
accumulated in the nucleus (Fig. 5L), suggesting thatthese cells had acquired a differentiation program that
leads to secretion.
Although Cx43 is highly expressed in the myoepithe-
lium, its loss did not alter the expression of the specific
markers SMA and K5 (data not shown), suggesting that
myoepithelial cells could develop in the absence of Cx43.
The presence and localization of all the markers demon-
strate that Cx26 is not involved in the process of differen-
tiation of the epithelium during pregnancy (data not shown)
and lactation. In addition, the known markers of contractile
function in mammary glands are present, indicating that the
survival problems of pups from Cx26 fl/fl; MC mice are
not likely due to a failure of milk ejection problem but to
an underdevelopment of the epithelium (Fig. 2K).
Loss of Cx26 does not adversely affect mammary epithelial
cell proliferation but results in increased apoptosis
The lack of full expansion of mammary epithelium
upon deletion of the Cx26 gene could be the result of
impaired cell proliferation or increased apoptosis. Exten-
sive proliferation occurs during the first few days of
pregnancy. To mimic early pregnancy and study cell
proliferation, acute hormone stimulation was performed
for 48 h. Cell proliferation in three wild type and three
Fig. 4. Southern blot analyses of the targeted Cx26 gene. (I) Structures of the wild-type, floxed and recombined Cx26 alleles. A neomycin cassette flanked by
two loxP sites was inserted into exon 2 and another loxP site was inserted 5V of exon 2 (Cohen-Salmon et al., 2002). Restriction of genomic DNAwith SpeI and
BamHI resulted in the following diagnostic fragments. Wild-type allele: 4 kbp; floxed allele: 6.1 kbp; Cre-mediated recombined allele: 2.1 kbp. (II) Southern
blot analyses. (A) Spleen DNA from a Cx26 fl/+; MC male. Note: The presence of 2.1-kbp fragments demonstrates the recombination event. (B) DNA from
mammary tissue from a Cx26 fl/+; MC female at day 15 of pregnancy. (C) DNA from mammary tissue from a Cx26 fl/fl; MC female at day 1 of lactation.
Note: The majority of the floxed alleles have undergone recombination. The remaining signal is likely due to the stromal compartment, in which neither the
MMTV-Cre nor the WAP-Cre transgenes are active. (D) DNA of mammary tissue from a Cx26 fl/fl; WC female at day 1 of lactation. (III) Analyses of Cx26
expression in parturing Wt and Cx26fl/fl; MC mice by IFC. Green, Cx26; red, E-cadherin. (A) Wild type, observe in yellow (white arrow) the expression of
Cx26 protein between two adjacent epithelial cells. (B) Cx26fl/fl; MC, Cx26 is absent from epithelium in this transgene at lactation day 1. Scale bar: 50 Am.
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females after injection of progesterone and estrogen. Pro-
liferating cells were counted after immunostaining with
anti-phosphorylated Histone-3 antibodies. No significantdifference was observed between wild-type and Cx26 fl/
fl; MC mammary tissue, indicating that the early loss of
Cx26 in mammary epithelium does not affect the ability of
the gland to proliferate (data not shown). Furthermore,
Fig. 5. Immunohistochemical analyses of lactating mammary tissue. (A–D) Wild type. (E–H) Cx26 fl/fl; WC. (I–L) Cx26 fl/fl; MC. (A, E, I) Staining with
anti h-catenin and K5 antibodies. (B, F, J) Staining with anti SMA and NKCC1 antibodies. (C, G, K) Staining with anti E-cadherin and Npt2b antibodies. (D,
H, L) Staining with Stat 5a and h-catenin. The expression of the different proteins in mutant and wild-type tissues was indistinguishable. Arrowheads,
myoepithelial cells; open arrowheads, luminal epithelial cells; arrows, baso-lateral epithelial cells; open arrows, apical epithelial cells; double arrows,
intranuclear localization of Stat5a. Scale bar: 50 Am.
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P13.5 and P15 (data not shown).
The extent of cell death in wild-type and Cx26 fl/fl;
MC mice was evaluated using TUNEL assays. In case the
impaired lactation would be caused by precocious apopto-
sis, we studied the glands at pregnancy day 19. While in
wild-type tissue 1.2 F 0.7% of the cells were apoptotic,5.6 F 2.1% were TUNEL positive in the Cx26 fl/fl; MC
mice (Fig. 6). Absence of Stat 3 nuclear protein staining in
the same samples confirmed that observed apoptosis was
not related to aberrant involution of the gland (data not
shown). This demonstrated that Cx26 is required for the
survival of mammary epithelium. Data were significant
with P < 0.005.
Fig. 6. Increased apoptosis in Cx26 fl/fl; MC mammary tissue. (A) The
apoptotic rate in Cx26 fl/fl; MC tissue at pregnancy day 19 was 5.6 F
2.1% versus 1.2 F 0.7% in the wild-type tissue. (B) TUNEL assay of wild-
type mammary tissue at parturition. (C) TUNEL assay of Cx26 fl/fl; MC
mammary tissue at parturition. Apoptotic cells are shown in red. The values
comparing Wt and Cx26 fl/fl; MC glands at parturition were significantly
different ( P < 0.005). Scale bar: 50 Am.
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tumors
It has been observed that connexins are frequently lost in
breast cancer (Carystinos et al., 2001), suggesting that Cx26
is a tumor suppressor (Hirschi et al., 1996; Muramatsu et al.,
2002). We tested this hypothesis and explored whether loss
of Cx26 in the mammary tissue would lead to the appear-
ance of tumors. Mammary tissue from five Cx26 fl/fl; WC
and five Cx26 fl/fl; MC was analyzed after five and three
pregnancies, respectively. No signs of hyperplasia and
tumors were detected, suggesting that the lack of Cx26 by
itself does not predispose the mouse to mammary tumors
(data not shown).Discussion
Through the use of four genetically altered mouse strains,
we were able to decipher the importance of Cx26 in
mammary gland development. While the loss of Cx32 and
the replacement of Cx43 with Cx32 did not adversely affect
mammary development and differentiation, ablation of the
Cx26 gene from mammary epithelium before puberty com-
promised alveolar development during pregnancy and func-
tion during lactation. In contrast, ablation of Cx26 during
the later part of pregnancy in the secretory epithelial
compartment did not adversely affect alveolar development
and function. Several conclusions can be drawn from these
findings. First, functional development of mammary alveo-
lar epithelium depends on the presence of Cx26 only during
the early phase of pregnancy. Loss of Cx26 in secretory
alveolar cells in the later part of pregnancy remains without
consequences. Second, Cx32 itself is either not required at
all or its absence can be compensated for by other connex-
ins. Third, myoepithelial cells form in the absence of Cx43.
The distinct expression patterns of connexins 26, 32 and
43 in mammary tissue during development (Locke et al.,
2000; Monaghan et al., 1994; Yamanaka et al., 2001) had
suggested defined functions in mammary physiology. Inac-
tivation of the Cx26 gene before puberty using the MMTV-
Cre mice demonstrated the need for this connexin in the
pregnancy-mediated alveolar development. Thus, Cx26
appears to have a unique and non-redundant role during
the early stages of pregnancy that are characterized by
alveolar cell proliferation. This function coincides with its
expression pattern during pregnancy (Locke et al., 2000).
Loss of Cx26 in the alveolar epithelium resulted in a sharp
increase of apoptosis without a major impairment of cell
proliferation. Controlling epithelial cell survival emerges as
a key function of Cx26. Similarly, inactivation of the Cx26
gene in the epithelial network of the inner ear does not
impair development per se but results in cell death within
the organ of Corti (Cohen-Salmon et al., 2002). At this
point, it is not clear which pathway controls cell survival and
death in mammary epithelium during pregnancy. Although
the Bcl-2 family of proteins controls the balance of cell
survival and death in several settings, loss of the most
prominent member in mammary epithelium, Bcl-x, does
not influence mammary epithelial cell survival during preg-
nancy (Walton et al., 2001). While Cx26 is required for
epithelial cell survival, it appears to be dispensable for cell
function, both in the inner ear (Cohen-Salmon et al., 2002)
and the mammary gland as shown in this study. Loss of
Cx26-containing epithelial gap junctions does not affect the
functioning of the vestibular apparatus or mammary secre-
tory epithelium. In Cx26-deficient mammary epithelium,
proteins linked to differentiation are expressed similar to
wild-type tissue and the failure of these mice to lactate
properly is probably due to the lack of sufficient amounts
of epithelium. Because mammary epithelial differentiation
occurs around parturition, the time when Cx32 is detected, it
C. Bry et al. / Developmental Biology 267 (2004) 418–429428can be speculated that the loss of Cx26 is compensated by
Cx32. In support of this, Cx26 and Cx32 are co-expressed in
acinar cells (Yamanaka et al., 2001) and organized as
homomeric and heteromeric connexins (Locke et al., 2000).
Loss of Stat5a (Liu et al., 1995) results in impaired
mammary development and function, which displays simi-
larities to that seen in Cx26-null mammary epithelium. In
particular, Stat5a is required for the survival of mammary
epithelium after parturition (Humphreys and Hennighausen,
1999). This suggests that Cx26 is a direct or indirect
downstream mediator of Stat5a. In support of this, a Stat5
binding site has been identified in the promoter of the Cx26
gene (Kiang et al., 1997). Moreover, the expression pattern
of the Cx26 gene during pregnancy is reminiscent of some
milk protein genes (Robinson and Hennighausen, 1997),
suggesting that it is under similar hormonal control.
Inactivation of the Cx26 gene in mammary secretory
epithelium during the late stage of pregnancy using WAP-
Cre transgenic mice did not lead to impaired development
and the tissue was functional as demonstrated by the
lactational performance of the dams. Because Cx32 is
expressed around parturition, it is likely that its presence
will compensate for the lack of Cx26. Similarly, loss of
Cx32 did not result in impaired alveolar function and
lactation and can be explained by the presence of Cx26
after parturition (Locke et al., 2000). Normal pregnancy-
mediated epithelial proliferation and development in the
absence of Cx32 might have been anticipated because
strong induction of Cx32 occurs only around parturition.
While in the mammary gland the lack of Cx32 has no
apparent impact on the lactational competence, its presence
in lacrimal glands is necessary for optimal fluid secretion
(Brink et al., 2002). The requirement for Cx26 and Cx32 in
the physiology of other secretory organs remains to be
determined.
It has been suggested that connexins function as
potent tumor suppressors (Hirschi et al., 1996; Mura-
matsu et al., 2002) and retroviral-mediated overexpression
of Cx26 in breast cancer cell lines resulted in a suppres-
sion of tumor growth in nude mice (Qin et al., 2002).
Similarly, introduction of Cx26 into malignant human
hepatoma cells reduced their malignant potential (Mura-
matsu et al., 2002). The in vivo significance of Cx26 as
a tumor suppressor was evaluated in mammary epitheli-
um from mice that had gone through several pregnancies.
No hyperproliferation or hyperplasia were observed, sug-
gesting that Cx26 is not a tumor suppressor in the
absence of additional genetic. To investigate further the
potential importance of Cx26 in mammary tumor devel-
opment, it would be necessary to introduce activated
oncogenes.
In the mammary gland, the presence of Cx43 is confined
to the myoepithelium (Pozzi et al., 1995) which is located at
the basal side of the secretory and ductal epithelium.
Ordered myoepithelium that expressed the characteristic
smooth muscle actin was present in mice in which theCx43 gene had been replaced with Cx32 alleles. This
suggests that either the loss of Cx43 can be compensated
by the presence of Cx32 or that ordered gap junctions
between the myoepithelium and the secretory epithelium
are not required for the establishment and presence of
myoepithelial cells.
In conclusion, of the connexins investigated (Cx26, Cx32
and Cx43), only Cx26 was shown to have a unique and non-
redundant role in mammary development. Deletion of the
Cx26 gene in mammary epithelium before pregnancy
resulted in increased apoptosis and a reduced alveolar
compartment. However, deletion of the Cx26 gene during
the later part of pregnancy did not abrogate mammary
development, which could be the result of compensation
by Cx32 that is expressed during this time window.References
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